Shifting Identities: How Lung Cancer Cells Change Face to Outsmart Treatment
A new review explains how small-cell lung cancer cells exploit lineage infidelity to switch molecular identities under therapy, and how ...
A new review explains how small-cell lung cancer cells exploit lineage infidelity to switch molecular identities under therapy, and how ...
A phase 1b study presented at the IASLC 2026 World Conference on Lung Cancer found that subcutaneous tarlatamab was well ...
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and ...
A Hidden RNA-Decay System May Be the Achilles’ Heel of Small-Cell Lung Cancer Small-cell lung cancer, one of the most ...
Small cell lung cancer (SCLC) accounts for approximately 15% of lung cancer diagnoses and remains one of oncology’s most aggressive ...
In a groundbreaking study published in Nature, researchers have unveiled compelling evidence that small cell lung cancer (SCLC) cells can ...
Recent groundbreaking research has unveiled a startling connection between small cell lung cancer (SCLC) and the nervous system, revealing that ...
In a groundbreaking study set to reshape our understanding of cancer biology, an international team of researchers has revealed that ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine